港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

467.212

-2.153-0.46%

漲家數：22

跌家數：28

平家數：5

市盈率：- -

高：469.921

開：469.365

低：464.319

收：469.365

資料載入中...

中國通號獲上海寧泉資產管理有限公司增持80萬股每股作價3.07港元

福萊特玻璃獲上海寧泉資產管理有限公司增持103.9萬股每股作價8.84港元

泰格醫藥(03347.HK)獲易方達基金增持16.35萬股

吉安縣華庭生活服務有限公司成立，註冊資本200萬人民幣

榮昌生物(09995.HK)偶聯藥維迪西妥單抗Ⅲ期臨牀研究達主要研究終點

阿斯达克财经

榮昌生物(09995.HK)注射用RC278臨牀試驗申請獲受理

阿斯达克财经

中證蘇州工業園區指數下跌0.47%，前十大權重包含信達生物等

侯孝海減持華潤啤酒(00291)63.8萬股每股作價28.04港元

和鉑醫藥-B月內連續第5日回購管理層對公司發展充滿信心

和鉑醫藥回購120萬股金額976萬港元

巴西貿易與投資促進機構：美團將投資約50億巴西雷亞爾，通過Keeta應用進入巴西外賣市場。

維升藥業那韋培肽完成中國2期臨牀試驗，用於治療軟骨發育不全

和鉑醫藥-B(02142)5月12日斥資976.04萬港元回購120萬股

因個人原因張浩川辭任招商證券副總裁

Eurizon：美債收益率上升令人擔憂，貿易會談未提振美債

翰宇藥業：與碳雲智肽簽署《GLP-1R/GIPR/GCGR三重激動劑多肽創新藥物聯合開發協議》

歸創通橋(02190)5月12日斥資93.3萬港元回購5萬股

摩根資產管理：中美經貿會談聯合聲明超預期風險釋放下市場反應積極

上海寧泉資產管理有限公司增持中國通號(03969)80萬股每股作價3.07港元

上海寧泉資產管理有限公司增持福萊特玻璃(06865)103.9萬股每股作價8.84港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=17"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":467.2124,"timestamp":1747382899099,"preClose":469.36545,"halted":0,"volume":479017705,"delay":0,"changeRate":-0.004587,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":-2.153046,"latestTime":"05-16 16:00:00","open":469.36545,"high":469.9207,"low":464.31912,"amount":14169967216,"amplitude":0.011934,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747618200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747359000000,1747368000000],[1747371600000,1747382400000]],"pbRate":2.217245,"peRate":21.280321,"turnoverRate":0.00334,"increases":24,"decrements":29,"flats":1,"marketCap":2655060965440,"floatMarketCap":2071376504896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":469.9207,"amplitude":0.011934,"preClose":469.36545,"low":464.31912,"pbRate":"2.217245","latestPrice":467.2124,"volume":479017705,"delay":0,"open":469.36545,"prevYearClose":446.93042,"prevWeekClose":480.539,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":480.539,"twentyDayClose":483.664,"sixtyDayClose":493.223,"secType":"PLATE","market":"HK","turnoverRate":0.00334,"peRate":21.280321,"marketCap":2655060965440,"floatMarketCap":2071376504896,"timestamp":1747382899099,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":22,"down":28,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:17,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535473658","title":"中國通號獲上海寧泉資產管理有限公司增持80萬股 每股作價3.07港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535473658","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535473658?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 07:14","pubTimestamp":1747091640,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，5月6日，上海宁泉资产管理有限公司增持中国通号（03969）80万股，每股作价3.07港元，总金额为245.6万港元。增持后最新持股数目约为2.37亿股，最新持股比例为12.03%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-13/doc-inewkmnc4585631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1542","BK1229","03969","BK0279","09983","BK1258","BK1179","BK1583","688009"],"gpt_icon":0},{"id":"2535736534","title":"福萊特玻璃獲上海寧泉資產管理有限公司增持103.9萬股 每股作價8.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535736534","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535736534?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 07:13","pubTimestamp":1747091580,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，5月6日，上海宁泉资产管理有限公司增持福莱特玻璃（06865）103.9万股，每股作价8.84港元，总金额约为918.48万港元。增持后最新持股数目为2253.1万股，最新持股比例为5.1%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-13/doc-inewkmnc4585443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1258","BK1554","BK1583","09983","BK1169","BK1542","BK1229","06865","BK1594"],"gpt_icon":0},{"id":"2535736520","title":"泰格醫藥(03347.HK)獲易方達基金增持16.35萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2535736520","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535736520?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 06:54","pubTimestamp":1747090443,"startTime":"0","endTime":"0","summary":"格隆汇5月13日丨根据联交所最新权益披露资料显示，2025年5月8日，泰格医药(03347.HK)获易方达基金管理有限公司在场内以每股均价27.2934港元增持16.35万股，涉资约446.25万港元。增持后，易方达基金管理有限公司最新持股数目为992.69万股，持股比例由7.93%上升至8.06%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/13065450326452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1146622755.USD","BK0174","BK0216","BK0077","03347","BK0028","BK1576","BK1583","300347","BK1141","LU1820825898.SGD"],"gpt_icon":0},{"id":"2535782714","title":"吉安縣華庭生活服務有限公司成立，註冊資本200萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2535782714","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535782714?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 04:51","pubTimestamp":1747083117,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，吉安县华庭生活服务有限公司成立，法定代表人为高杰，注册资本200万人民币，由江西华庭物业服务有限公司全资持股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/13045150326272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09983","BK1229","BK1542","BK1583","BK1258"],"gpt_icon":0},{"id":"2534709432","title":"榮昌生物(09995.HK)偶聯藥維迪西妥單抗Ⅲ期臨牀研究達主要研究終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2534709432","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534709432?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 22:46","pubTimestamp":1747061160,"startTime":"0","endTime":"0","summary":"荣昌生物(09995.HK) 公布，公司自主研发的抗体偶联药物(ADC)维迪西妥单抗联合特瑞普利单抗对比化疗治疗HER2表达的一线局部晚期或转移性尿路上皮癌的Ⅲ期临床研究达到无进展生存期和总生存期两项主要研究终点。公司将择机向国家药品监督管理局药品审评中心递交该适应症的新药上市申请。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-12 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1439328/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2148510915.USD","688331","LU1064130708.USD","BK1583","BK1161","LU1969619763.USD","LU2328871848.SGD","BK1574","LU1064131003.USD","09995","BK0239"],"gpt_icon":0},{"id":"2534270941","title":"榮昌生物(09995.HK)注射用RC278臨牀試驗申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2534270941","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534270941?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 22:45","pubTimestamp":1747061100,"startTime":"0","endTime":"0","summary":"荣昌生物(09995.HK) 公布，近日收到国家药品监督管理局通知，公司自主研发的新型抗体偶联(ADC)药物注射用RC278的临床试验申请获得受理。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-12 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1439326/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1064130708.USD","BK1141","BK1583","LU1969619763.USD","BK1574","09995","LU1064131003.USD","LU2148510915.USD","BK1576","BK1161","LU2328871848.SGD","688331","03347","BK0239"],"gpt_icon":0},{"id":"2534206740","title":"中證蘇州工業園區指數下跌0.47%，前十大權重包含信達生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2534206740","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534206740?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 19:59","pubTimestamp":1747051191,"startTime":"0","endTime":"0","summary":"数据统计显示，中证苏州工业园区指数近一个月上涨5.45%，近三个月上涨6.19%，年至今上涨7.48%。从中证苏州工业园区指数持仓的市场板块来看，深圳证券交易所占比38.47%、上海证券交易所占比36.59%、香港证券交易所占比24.46%、北京证券交易所占比0.49%。从中证苏州工业园区指数持仓样本的行业来看，信息技术占比27.17%、医药卫生占比23.02%、金融占比16.92%、工业占比14.39%、可选消费占比10.23%、通信服务占比7.40%、房地产占比0.55%、原材料占比0.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051220365294f47593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051220365294f47593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","LU2488822045.USD","BK1583","01801","LU1969619763.USD","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2534221126","title":"侯孝海減持華潤啤酒(00291)63.8萬股 每股作價28.04港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534221126","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534221126?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 19:41","pubTimestamp":1747050066,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联交所最新资料显示，5月7日，侯孝海减持华润啤酒(00291)63.8万股，每股作价28.04港元，总金额约为1788.95万港元。减持后最新持股数目为38万股，最新持股比例0.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","LU1328615791.USD","LU1023057109.AUD","BK1604","IE00B5MMRT66.SGD","00291","LU1720050803.USD","IE00BPRC5H50.USD","BK1180","IE00B29SXG58.USD","LU1794554557.SGD","CRHKY","IE00B031HY20.USD","LU0359201612.USD","BK1510","80291","IE00B543WZ88.USD","LU0359202008.SGD","BK1570","BK1589","SG9999006514.SGD","BK1583","BK1578","IE0031814852.USD","IE00B0169L03.USD","BK1521","IE0008368742.USD"],"gpt_icon":0},{"id":"2534227114","title":"和鉑醫藥-B月內連續第5日回購 管理層對公司發展充滿信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2534227114","media":"格隆汇","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534227114?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 19:32","pubTimestamp":1747049566,"startTime":"0","endTime":"0","summary":"格隆汇5月12日｜港交所披露数据显示，和铂医药-B(02142.HK)5月12日耗资976.03万港元回购120万股。据统计，截至今日，该股月内已连续5日进行回购操作，共计耗资2968.6万港元，累计回购358.8万股。近日连续回购充分展现了公司管理层对未来业务发展的积极预期和坚定信心。在当前复杂多变的市场环境下，这一举措也体现了管理层对公司长期价值的认可，以及对提升股东回报的重视。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512193246975729b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512193246975729b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2534226335","title":"和鉑醫藥回購120萬股 金額976萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534226335","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534226335?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 19:09","pubTimestamp":1747048182,"startTime":"0","endTime":"0","summary":"和铂医药-B（02142）发布公告，2025年5月12日，公司回购股份120万股，回购金额为976万港元。根据回购授权的决议，公司可回购的股份总数为7689万股，已回购股份1822万股，占回购授权决议通过时已发行股份的2.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505123402190831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02142","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2534771225","title":"巴西貿易與投資促進機構：美團將投資約50億巴西雷亞爾，通過Keeta應用進入巴西外賣市場。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534771225","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534771225?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 19:09","pubTimestamp":1747048163,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0878005551.USD","BK1591","LU0049853897.USD","LU0823039010.USD","LU1048596156.SGD","LU0577902298.EUR","LU0417516902.SGD","LU0164872284.USD","LU0856984785.SGD","LU1675838814.USD","LU0543330483.HKD","LU1328277881.USD","LU0143863784.USD","LU1868837722.USD","LU0181495838.USD","LU1105468828.SGD","LU1328615791.USD","LU1720050803.USD","LU0611395673.USD","LU0589944569.HKD","LU0348735423.USD","BK1142","BK1575","MPNGY","LU0737861699.HKD","LU0140636845.USD","LU2242644610.SGD","LU1960683339.HKD","LU2097828714.EUR","BK1618","LU0072462343.USD","LU0261950983.USD","LU2097828631.EUR","03690","METmain","LU1242518931.SGD","LU0143863198.USD","LU0320764755.SGD","LU1242518857.USD","HMTD.SI","LU0431992006.USD","LU2125910500.SGD","BK1610","LU0501845795.SGD","LU0132412106.USD","LU0541501648.USD","LU0797268264.HKD","LU0865486749.SGD","LU2039709279.SGD","BK1583"],"gpt_icon":0},{"id":"2534291132","title":"維升藥業那韋培肽完成中國2期臨牀試驗，用於治療軟骨發育不全","url":"https://stock-news.laohu8.com/highlight/detail?id=2534291132","media":"时代财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534291132?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:55","pubTimestamp":1747047306,"startTime":"0","endTime":"0","summary":"本文来源：时代财经5月12日，维升药业宣布其在研的用于治疗软骨发育不全的那韦培肽中国 2 期临床试验已全部顺利完成，并于近期在国家药监局“药物临床试验登记与信息公示平台”登记临床试验结果信息。据维升药业介绍，那韦培肽中国2期临床试验针对中国2至10岁ACH患儿，采用每周一次皮下给药的方式，旨在安全治疗剂量下持续提供活性CNP。另据沙利文数据，2023年中国软骨发育不全的患病人数为5.12万例，其中可以治疗的儿童约1万例。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051219180797572666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051219180797572666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1161","03347","02561","BK1583","BK1576"],"gpt_icon":0},{"id":"2534223347","title":"和鉑醫藥-B(02142)5月12日斥資976.04萬港元回購120萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2534223347","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534223347?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:50","pubTimestamp":1747047057,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2025年5月12日斥资976.04万港元回购120万股股份，每股回购价格为7.96-8.58港元。于同日，根据于2020年11月23日采纳及获公司股东批准的首次公开发售后股份奖励计划而发行2万股普通股以满足股份奖励。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2534240166","title":"因個人原因 張浩川辭任招商證券副總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2534240166","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534240166?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:42","pubTimestamp":1747046541,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999012710.SGD","SG9999012736.USD","BK1564","BK0183","SG9999012744.USD","601628","BK0010","BK0196","LU0307460666.USD","BK1521","LU1046422090.SGD","BK1584","SG9999012728.SGD","LU0588546209.SGD","BK1229","BK1550","BK1184","BK1583","IE0032431581.USD","BK0028","BK1258","09983","LU0287142896.SGD","BK0207","BK0012","06099","BK0188","LU0173614495.USD","BK1542","600999","BK0276","BK1147","02628"],"gpt_icon":0},{"id":"2534524016","title":"Eurizon：美債收益率上升令人擔憂，貿易會談未提振美債","url":"https://stock-news.laohu8.com/highlight/detail?id=2534524016","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534524016?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:42","pubTimestamp":1747046534,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["UTRE","ZBmain","BK1583","UFIV","09141","BK1229","BK4585","UTHY","TLT","BND","US10Y.BOND","US7Y.BOND","09983","ZFmain","GOVT","BK1258","BK4588","ZNmain","ZTmain","US2Y.BOND","US3Y.BOND","USVN","IEF","UTWY","US30Y.BOND","TNmain","BK1542","US6M.BOND","IEI","US5Y.BOND","US12M.BOND","SHY","UBmain"],"gpt_icon":0},{"id":"2534687242","title":"翰宇藥業：與碳雲智肽簽署《GLP-1R/GIPR/GCGR三重激動劑多肽創新藥物聯合開發協議》","url":"https://stock-news.laohu8.com/highlight/detail?id=2534687242","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534687242?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:22","pubTimestamp":1747045360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["GLP","GIPR","300199","159992","BK1583","BK0239","BK0188","03347","BK0028","BK0077","BK1161","BK4160","BK1141","06978","BK1574","BK4144","BK4590","BK1576","BK0070"],"gpt_icon":0},{"id":"2534241831","title":"歸創通橋(02190)5月12日斥資93.3萬港元回購5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2534241831","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534241831?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 18:06","pubTimestamp":1747044394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2025年5月12日斥资93.3万港元回购5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","02190","BK1587","BK1100"],"gpt_icon":0},{"id":"2534246801","title":"摩根資產管理：中美經貿會談聯合聲明超預期 風險釋放下市場反應積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2534246801","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534246801?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 17:53","pubTimestamp":1747043580,"startTime":"0","endTime":"0","summary":"刚公布的中美日内瓦经贸会谈联合声明，内容显示中美双方相信持续的协商有助于解决双方在经贸领域关切的问题；双方决定自5月14日，美国将（一）修改2025年4月2日第14257号行政令中规定的对中国商品加征的从价关税，其中，24%的关税在初始的90天内暂停实施，同时保留按该行政令的规定对这些商品加征剩余10%的关税；（二）取消根据2025年4月8日第14259号行政令和2025年4月9日第14266号行政令对这些商品的加征关税。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/2025-05-12/doc-inewicst5228154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1229","BK1542","BK1258","09983","BK1583"],"gpt_icon":0},{"id":"2534454322","title":"上海寧泉資產管理有限公司增持中國通號(03969)80萬股 每股作價3.07港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534454322","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534454322?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 17:50","pubTimestamp":1747043442,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月6日，上海宁泉资产管理有限公司增持中国通号(03969)80万股，每股作价3.07港元，总金额为245.6万港元。增持后最新持股数目约为2.37亿股，最新持股比例为12.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1179","BK1229","BK1258","03969","BK0279","688009","BK1583","BK1542","09983"],"gpt_icon":0},{"id":"2534245437","title":"上海寧泉資產管理有限公司增持福萊特玻璃(06865)103.9萬股 每股作價8.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534245437","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534245437?lang=zh_tw&edition=fundamental","pubTime":"2025-05-12 17:48","pubTimestamp":1747043323,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月6日，上海宁泉资产管理有限公司增持福莱特玻璃(06865)103.9万股，每股作价8.84港元，总金额约为918.48万港元。增持后最新持股数目为2253.1万股，最新持股比例为5.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1594","09983","BK1258","BK1169","06865","BK1542","BK1554","BK1229"],"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":17,"totalSize":777,"code":"91000000","status":"200"}]}}